TEST BANK for Little and Falace's Dental Management
of the Medically Compromised Patient, 10th Edition
by Craig Miller, Verified Chapters 1 – 30
,Table of Content
PART ONE: PATIENT EVALUATION AND RISK ASSESSMENT
Chapter 1: Patient Evaluation and Risk Assessment
PART TWO: CARDIOVASCULAR DISEASE
Chapter 2: Infective Endocarditis
Chapter 3: Hypertension
Chapter 4: Ischemic Heart Disease
Chapter 5: Cardiac Arrhythmias
Chapter 6: Heart Failure (or Congestive Heart Failure)
PART THREE: PULMONARY DISEASE
Chapter 7: Pulmonary Disease
Chapter 8: Smoking and Tobacco Use Cessation
Chapter 9: Sleep-Related Breathing Disorders
PART FOUR: GASTROINTESTIAL DISEASE
Chapter 10: Liver Disease
Chapter 11: Gastrointestinal Disease
PART FIVE: GENITOURINARY DISEASE
Chapter 12: Chronic Kidney Disease and Dialysis
Chapter 13: Sexually Transmitted Diseases
PART SIX: ENDOCRINE AND METABOLIC DISEASE
Chapter 14: Diabetes Mellitus
Chapter 15: Adrenal Insufficiency
Chapter 16: Thyroid Diseases
Chapter 17: Pregnancy and Breast Feeding
PART SEVEN: IMMUNOLOGIC DISEASE
Chapter 18: AIDS, HIV Infection, and Related Conditions
Chapter 19: Allergy
Chapter 20: Rheumatologic and Connective Tissue Disorders
Chapter 21: Organ and Bone Marrow Transplantation
PART EIGHT: HEMATOLOGIC AND ONCOLOGIC DISEASE
Chapter 22: Disorders of Red Blood Cells
Chapter 23: Disorders of White Blood Cells
Chapter 24: Acquired Bleeding and Hypercoagulable Disorders
Chapter 25: Congenital Bleeding and Hypercoagulable Disorders
Chapter 26: Cancer and Oral Care of the Patient
PART NINE: NEUROLOGIC, BEHAVIORAL, AND PSYCHIATRIC DISORDERS
Chapter 27: Neurologic Disorders
Chapter 28: Anxiety, Eating Disorders, and Behavioral Reactions to Illness
Chapter 29: Psychiatric Disorders
Chapter 30: Drug and Alcohol Abuse
,ChapterY01: YPatient YEvaluation Yand YRisk YAssessment
Little: YDental YManagement Yof Ythe YMedically YCompromised YPatient, Y10thYEdition
MULTIPLE YCHOICE
1. Elective Ydental Ycare Yshould Ybe Ydeferred Yfor Ypatients Ywith Ysevere, Yuncontrolled
Y hypertension, Ymeaning Ythat Ythe Yblood Ypressure Yis Ygreater Ythan Yor Yequal Yto Y Y Y
Ymm YHg.
a. 200/140
b. 180/140
c. 180/110
d. 160/110
ANS: YC
Elective Y dental Y care Y should Y be Y deferred Y for Y patients Y with Y severe,
Y uncontrolled Y hypertension, Ywhich Yis Yblood Ypressure Ygreater Ythan Yor Yequal Yto
Y180/110 Ymm YHg, Yuntil Y the Ycondition Ycan Ybe Ybrought Yunder Ycontrol.
2. The YAmerican YHeart YAssociation Ycurrently Yrecommends Yantibiotic Yprophylaxis
Yfor Ya Y patient Ywith Ywhich Yof Ythe Yfollowing Ycardiac Yconditions?
a. Mitral Yvalve Yprolapse
b. Prosthetic Yheart Yvalve
c. Rheumatic Yheart Ydisease
d. Pacemakers Yfor Ycardiac Yarrhythmias
ANS: YB
Previously, Ythe YAmerican YHeart YAssociation Y(AHA) Yrecommended Yantibiotic
Yprophylaxis Y for Ymany Ypatients Ywith Yheart Ymurmurs Ycaused Yby Yvalvular Ydisease
Y(e.g., Ymitral Yvalve Y prolapse, Yrheumatic Yheart Ydisease) Yin Yan Yeffort Yto Yprevent
Yinfective Yendocarditis; Y however, Ycurrent Yguidelines Yomit Ythis Yrecommendation Yon
Ythe Ybasis Yof Yaccumulated Y scientific Yevidence. YIf Ya Ymurmur Yis Ydue Yto Ycertain
Yspecific Ycardiac Yconditions Y(e.g., Y previous Yendocarditis, Yprosthetic Yheart Yvalve,
Ycomplex Ycongenital Ycyanotic Yheart Y disease), Ythe YAHA Ycontinues Yto Yrecommend
Yantibiotic Yprophylaxis Yfor Ymost Ydental Y procedures.
3. One Yconsequence Yof Ychronic Yhepatitis Y(B Yor YC) Yor Ycirrhosis Yof Ythe Yliver Yis
Ydecreased Y ability Yof Ythe Ybody Yto Y Y Ycertain Ydrugs, Yincluding Ylocal Yanesthetics
Yand Yanalgesics.
a. absorb
b. distribute
c. metabolize
d. excrete
ANS: YC
Patients Yalso Ymay Yhave Ychronic Yhepatitis Y(B Yor Y C) Yor Ycirrhosis, Ywith
Y impairment Y of Y liver Y function. Y This Y deficit Y may Y result Y in Y prolonged
Y bleeding Y and Y less Y efficient Y metabolism Yof Ycertain Ydrugs, Yincluding Ylocal
Yanesthetics Yand Yanalgesics.
4. Which Yof Ythe Yfollowing Ysymptoms Yand Ysigns Yis Ymost Yconsistent Ywith Yallergy?
a. Heart Ypalpitations
b. Itching
c. Vomiting
d. Fainting
, ANS: YB
Symptoms Yand Ysigns Yconsistent Ywith Yallergy Yinclude Yitching, Yurticaria Y(hives), Yrash,
Y swelling, Ywheezing, Yangioedema, Yrunny Ynose, Yand Ytearing Yeyes. YIsolated Ysigns Yand
Y symptoms Ysuch Yas Ynausea, Yvomiting, Yheart Ypalpitations, Yand Yfainting Ygenerally Yare
Ynot Y of Yan Yallergic Yorigin Ybut Yrather Yare Ymanifestations Yof Ydrug Yintolerance,
Yadverse Yside Y effects, Yor Ypsychogenic Yreactions.
5. Which Yof Ythe Yfollowing Yis Ytrue Yof Ythe Ypatient Ywith Ya Yhistory Yof Ytuberculosis?
a. A Ypositive Yresult Yon Yskin Ytesting Ymeans Ythat Ythe Yperson Yhas Yactive YTB.
b. Most Ypatients Ywho Ybecome Ypositive Yskin Ytesters Ydevelop Yactive Ydisease.
c. Patients Ywith Yacquired Yimmunodeficiency Ysyndrome Y(AIDS) Yhave Ya
high Y incidence Yof Ytuberculosis.
Y
d. A Ydiagnosis Yof Yactive YTB Yis Ymade Yby Ya Ypurified Yprotein Yderivative Y(PPD) Yskin Ytest.
ANS: Y Y C
The Ypotential Ycoexistence Yof Ytuberculosis Yand Yacquired Yimmunodeficiency Ysyndrome
Y (AIDS) Yshould Ybe Yexplored Ybecause Ypatients Ywith YAIDS Yhave Ya Yhigh Yincidence Yof
Y tuberculosis. YA Ypositive Yresult Yon Yskin Ytesting Ymeans Yspecifically Ythat Ythe Yperson
Yhas Yat Y some Ytime Ybeen Yinfected Ywith YTB, Ynot Ynecessarily Ythat Yactive Ydisease Yis
Ypresent. YMost Y patients Ywho Ybecome Ypositive Yskin Ytesters Ydo Ynot Ydevelop Yactive
Ydisease. YA Ydiagnosis Yof Y active YTB Yis Ymade Yby Ychest Yx-ray, Yimaging, Ysputum
Yculture, Yand Yclinical Yexamination.
6. Vasoconstrictors Yshould Ybe Yavoided Yin Ypatients Ywho Ycocaine Yor
Ymethamphetamine Y users Ybecause Ythese Yagents Ymay Yprecipitate Y Y Y Y .
a. severeYhypotension
b. severeYhypertension
c. respiratoryYdepression
d. cessation Yof Yintestinal Yperistalsis
ANS: YB
Vasoconstrictors Yshould Ybe Yavoided Yin Ypatients Ywho Yare Ycocaine Yor Ymethamphetamine
Y users Ybecause Ythe Ycombination Ymay Yprecipitate Yarrhythmias, YMI, Yor Ysevere
Yhypertension.
7. It Yhas Ybeen Yshown Ythat Ythe Yrisk Yfor Yoccurrence Yof Ya Yserious Yperioperative
Ycardiovascular Y event Y(e.g., YMI, Yheart Yfailure) Yis Yincreased Yin Ypatients Ywho Yare
Yunable Yto Ymeet Ya Y-MET Y (metabolic Yequivalent Yof Ytask) Ydemand Yduring Ynormal
Ydaily Yactivity.
a. 4
b. 6
c. 8
d. 10
ANS: YA
Daily Yactivities Yrequiring Y4 YMETs Yinclude Ylevel Ywalking Yat Y4 Ymiles/hour Yor Yclimbing Ya
Yflight Y of Ystairs. YActivities Yrequiring Ygreater Ythan Y10 YMETs Yinclude Yswimming Yand
Ysingles Ytennis. Y An Yexercise Ycapacity Yof Y10 Yto Y13 YMETs Yindicates Yexcellent Yphysical
Yconditioning.
8. Which Yof Ythe Yfollowing Yalterations Yin Ythe Yfingernails Yis Yassociated Ywith Ycirrhosis?
a. Yellowing
b. Clubbing
c. White Ydiscoloration
d. SplinterYhemorrhages
of the Medically Compromised Patient, 10th Edition
by Craig Miller, Verified Chapters 1 – 30
,Table of Content
PART ONE: PATIENT EVALUATION AND RISK ASSESSMENT
Chapter 1: Patient Evaluation and Risk Assessment
PART TWO: CARDIOVASCULAR DISEASE
Chapter 2: Infective Endocarditis
Chapter 3: Hypertension
Chapter 4: Ischemic Heart Disease
Chapter 5: Cardiac Arrhythmias
Chapter 6: Heart Failure (or Congestive Heart Failure)
PART THREE: PULMONARY DISEASE
Chapter 7: Pulmonary Disease
Chapter 8: Smoking and Tobacco Use Cessation
Chapter 9: Sleep-Related Breathing Disorders
PART FOUR: GASTROINTESTIAL DISEASE
Chapter 10: Liver Disease
Chapter 11: Gastrointestinal Disease
PART FIVE: GENITOURINARY DISEASE
Chapter 12: Chronic Kidney Disease and Dialysis
Chapter 13: Sexually Transmitted Diseases
PART SIX: ENDOCRINE AND METABOLIC DISEASE
Chapter 14: Diabetes Mellitus
Chapter 15: Adrenal Insufficiency
Chapter 16: Thyroid Diseases
Chapter 17: Pregnancy and Breast Feeding
PART SEVEN: IMMUNOLOGIC DISEASE
Chapter 18: AIDS, HIV Infection, and Related Conditions
Chapter 19: Allergy
Chapter 20: Rheumatologic and Connective Tissue Disorders
Chapter 21: Organ and Bone Marrow Transplantation
PART EIGHT: HEMATOLOGIC AND ONCOLOGIC DISEASE
Chapter 22: Disorders of Red Blood Cells
Chapter 23: Disorders of White Blood Cells
Chapter 24: Acquired Bleeding and Hypercoagulable Disorders
Chapter 25: Congenital Bleeding and Hypercoagulable Disorders
Chapter 26: Cancer and Oral Care of the Patient
PART NINE: NEUROLOGIC, BEHAVIORAL, AND PSYCHIATRIC DISORDERS
Chapter 27: Neurologic Disorders
Chapter 28: Anxiety, Eating Disorders, and Behavioral Reactions to Illness
Chapter 29: Psychiatric Disorders
Chapter 30: Drug and Alcohol Abuse
,ChapterY01: YPatient YEvaluation Yand YRisk YAssessment
Little: YDental YManagement Yof Ythe YMedically YCompromised YPatient, Y10thYEdition
MULTIPLE YCHOICE
1. Elective Ydental Ycare Yshould Ybe Ydeferred Yfor Ypatients Ywith Ysevere, Yuncontrolled
Y hypertension, Ymeaning Ythat Ythe Yblood Ypressure Yis Ygreater Ythan Yor Yequal Yto Y Y Y
Ymm YHg.
a. 200/140
b. 180/140
c. 180/110
d. 160/110
ANS: YC
Elective Y dental Y care Y should Y be Y deferred Y for Y patients Y with Y severe,
Y uncontrolled Y hypertension, Ywhich Yis Yblood Ypressure Ygreater Ythan Yor Yequal Yto
Y180/110 Ymm YHg, Yuntil Y the Ycondition Ycan Ybe Ybrought Yunder Ycontrol.
2. The YAmerican YHeart YAssociation Ycurrently Yrecommends Yantibiotic Yprophylaxis
Yfor Ya Y patient Ywith Ywhich Yof Ythe Yfollowing Ycardiac Yconditions?
a. Mitral Yvalve Yprolapse
b. Prosthetic Yheart Yvalve
c. Rheumatic Yheart Ydisease
d. Pacemakers Yfor Ycardiac Yarrhythmias
ANS: YB
Previously, Ythe YAmerican YHeart YAssociation Y(AHA) Yrecommended Yantibiotic
Yprophylaxis Y for Ymany Ypatients Ywith Yheart Ymurmurs Ycaused Yby Yvalvular Ydisease
Y(e.g., Ymitral Yvalve Y prolapse, Yrheumatic Yheart Ydisease) Yin Yan Yeffort Yto Yprevent
Yinfective Yendocarditis; Y however, Ycurrent Yguidelines Yomit Ythis Yrecommendation Yon
Ythe Ybasis Yof Yaccumulated Y scientific Yevidence. YIf Ya Ymurmur Yis Ydue Yto Ycertain
Yspecific Ycardiac Yconditions Y(e.g., Y previous Yendocarditis, Yprosthetic Yheart Yvalve,
Ycomplex Ycongenital Ycyanotic Yheart Y disease), Ythe YAHA Ycontinues Yto Yrecommend
Yantibiotic Yprophylaxis Yfor Ymost Ydental Y procedures.
3. One Yconsequence Yof Ychronic Yhepatitis Y(B Yor YC) Yor Ycirrhosis Yof Ythe Yliver Yis
Ydecreased Y ability Yof Ythe Ybody Yto Y Y Ycertain Ydrugs, Yincluding Ylocal Yanesthetics
Yand Yanalgesics.
a. absorb
b. distribute
c. metabolize
d. excrete
ANS: YC
Patients Yalso Ymay Yhave Ychronic Yhepatitis Y(B Yor Y C) Yor Ycirrhosis, Ywith
Y impairment Y of Y liver Y function. Y This Y deficit Y may Y result Y in Y prolonged
Y bleeding Y and Y less Y efficient Y metabolism Yof Ycertain Ydrugs, Yincluding Ylocal
Yanesthetics Yand Yanalgesics.
4. Which Yof Ythe Yfollowing Ysymptoms Yand Ysigns Yis Ymost Yconsistent Ywith Yallergy?
a. Heart Ypalpitations
b. Itching
c. Vomiting
d. Fainting
, ANS: YB
Symptoms Yand Ysigns Yconsistent Ywith Yallergy Yinclude Yitching, Yurticaria Y(hives), Yrash,
Y swelling, Ywheezing, Yangioedema, Yrunny Ynose, Yand Ytearing Yeyes. YIsolated Ysigns Yand
Y symptoms Ysuch Yas Ynausea, Yvomiting, Yheart Ypalpitations, Yand Yfainting Ygenerally Yare
Ynot Y of Yan Yallergic Yorigin Ybut Yrather Yare Ymanifestations Yof Ydrug Yintolerance,
Yadverse Yside Y effects, Yor Ypsychogenic Yreactions.
5. Which Yof Ythe Yfollowing Yis Ytrue Yof Ythe Ypatient Ywith Ya Yhistory Yof Ytuberculosis?
a. A Ypositive Yresult Yon Yskin Ytesting Ymeans Ythat Ythe Yperson Yhas Yactive YTB.
b. Most Ypatients Ywho Ybecome Ypositive Yskin Ytesters Ydevelop Yactive Ydisease.
c. Patients Ywith Yacquired Yimmunodeficiency Ysyndrome Y(AIDS) Yhave Ya
high Y incidence Yof Ytuberculosis.
Y
d. A Ydiagnosis Yof Yactive YTB Yis Ymade Yby Ya Ypurified Yprotein Yderivative Y(PPD) Yskin Ytest.
ANS: Y Y C
The Ypotential Ycoexistence Yof Ytuberculosis Yand Yacquired Yimmunodeficiency Ysyndrome
Y (AIDS) Yshould Ybe Yexplored Ybecause Ypatients Ywith YAIDS Yhave Ya Yhigh Yincidence Yof
Y tuberculosis. YA Ypositive Yresult Yon Yskin Ytesting Ymeans Yspecifically Ythat Ythe Yperson
Yhas Yat Y some Ytime Ybeen Yinfected Ywith YTB, Ynot Ynecessarily Ythat Yactive Ydisease Yis
Ypresent. YMost Y patients Ywho Ybecome Ypositive Yskin Ytesters Ydo Ynot Ydevelop Yactive
Ydisease. YA Ydiagnosis Yof Y active YTB Yis Ymade Yby Ychest Yx-ray, Yimaging, Ysputum
Yculture, Yand Yclinical Yexamination.
6. Vasoconstrictors Yshould Ybe Yavoided Yin Ypatients Ywho Ycocaine Yor
Ymethamphetamine Y users Ybecause Ythese Yagents Ymay Yprecipitate Y Y Y Y .
a. severeYhypotension
b. severeYhypertension
c. respiratoryYdepression
d. cessation Yof Yintestinal Yperistalsis
ANS: YB
Vasoconstrictors Yshould Ybe Yavoided Yin Ypatients Ywho Yare Ycocaine Yor Ymethamphetamine
Y users Ybecause Ythe Ycombination Ymay Yprecipitate Yarrhythmias, YMI, Yor Ysevere
Yhypertension.
7. It Yhas Ybeen Yshown Ythat Ythe Yrisk Yfor Yoccurrence Yof Ya Yserious Yperioperative
Ycardiovascular Y event Y(e.g., YMI, Yheart Yfailure) Yis Yincreased Yin Ypatients Ywho Yare
Yunable Yto Ymeet Ya Y-MET Y (metabolic Yequivalent Yof Ytask) Ydemand Yduring Ynormal
Ydaily Yactivity.
a. 4
b. 6
c. 8
d. 10
ANS: YA
Daily Yactivities Yrequiring Y4 YMETs Yinclude Ylevel Ywalking Yat Y4 Ymiles/hour Yor Yclimbing Ya
Yflight Y of Ystairs. YActivities Yrequiring Ygreater Ythan Y10 YMETs Yinclude Yswimming Yand
Ysingles Ytennis. Y An Yexercise Ycapacity Yof Y10 Yto Y13 YMETs Yindicates Yexcellent Yphysical
Yconditioning.
8. Which Yof Ythe Yfollowing Yalterations Yin Ythe Yfingernails Yis Yassociated Ywith Ycirrhosis?
a. Yellowing
b. Clubbing
c. White Ydiscoloration
d. SplinterYhemorrhages
